Showing results (31-40 of 217) with videos related to
Sort By:
Pageof 22
Journal of Pharmacokinetics and Pharmacodynamics|June 11, 2011
Population Fisher information matrix and optimal design of discrete data responses in population pharmacodynamic experimentsKayode Ogungbenro, Leon AaronsJournal of Biopharmaceutical Statistics|July 9, 2008
Analytical expressions for combining population pharmacokinetic parameters from different studiesAristides Dokoumetzidis, Leon AaronsJournal of Pharmacokinetics and Pharmacodynamics|November 26, 2009
A method for robust model order reduction in pharmacokineticsAristides Dokoumetzidis, Leon AaronsJournal of Biopharmaceutical Statistics|November 11, 2008
Sample size calculations for population pharmacodynamic experiments involving repeated dichotomous observationsKayode Ogungbenro, Leon AaronsJournal of Biopharmaceutical Statistics|September 22, 2007
Bayesian optimal designs for pharmacokinetic models: sensitivity to uncertaintyAristides Dokoumetzidis, Leon AaronsJournal of Pharmacokinetics and Pharmacodynamics|December 14, 2005
Propagation of population PK and PD information using a Bayesian approach: dealing with non-exchangeabilityAristides Dokoumetzidis, Leon AaronsPharmaceutical Research|July 24, 2014
A physiologically based pharmacokinetic model for clobazam and stiripentol in adults and childrenKayode Ogungbenro, Leon Aarons, Journal of Pharmacokinetics and Pharmacodynamics|December 15, 2015
What do we mean by identifiability in mixed effects models?Marc Lavielle, Leon AaronsJournal of Pharmacokinetics and Pharmacodynamics|March 22, 2014
Physiologically based pharmacokinetic modelling of methotrexate and 6-mercaptopurine in adults and children. Part 1: methotrexateKayode Ogungbenro, Leon Aarons, Clinical Pharmacokinetics|March 11, 2010
Predictions of metabolic drug-drug interactions using physiologically based modelling: Two cytochrome P450 3A4 substrates coadministered with ketoconazole or verapamilNathalie Perdaems, Helene Blasco, Cedric Vinson, et al.Pageof 22